Aurinia Pharmaceuticals Eulerpool News

Aurinia Pharmaceuticals Eulerpool News

Aurinia Pharmaceuticals Stock News

Aurinia Pharmaceuticals is being monitored by journalists and investors worldwide. We gather the latest Aurinia Pharmaceuticals news here.

• October 11 ·

  Stock Options Channel
  Commit To Buy Aurinia Pharmaceuticals At $5, Earn 16% Using Options
• October 11 ·

  Yahoo
  Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024
• October 11 ·

  TipRanks
  Aurinia Pharmaceuticals Showcases LUPKYNIS’s Impact at ASN 2024
• September 27 ·

  Yahoo
  Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Could Be Less Than A Year Away From Profitability
• September 24 ·

  Yahoo
  Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis
• September 24 ·

  Business Wire
  Aurinia Announces Japan Approval of LUPKYNIS? (Voclosporin) to Treat Lupus Nephritis
• September 19 ·

  SeekingAlpha
  3 Small Biotech Stocks With The 'Big Mo' Right Now
• September 19 ·

  SeekingAlpha
  Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment
• September 18 ·

  SeekingAlpha
  Aurinia Pharmaceuticals: This Recovery Can Continue
• September 13 ·

  Seeking Alpha
  Aurinia Pharmaceuticals shares gain as co reports Board restructuring